These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25460043)

  • 1. Regulation of DNA damage responses and cell cycle progression by hMOB2.
    Gomez V; Gundogdu R; Gomez M; Hoa L; Panchal N; O'Driscoll M; Hergovich A
    Cell Signal; 2015 Feb; 27(2):326-39. PubMed ID: 25460043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated cyclin G2 expression intersects with DNA damage checkpoint signaling and is required for a potent G2/M checkpoint arrest response to doxorubicin.
    Zimmermann M; Arachchige-Don AS; Donaldson MS; Dallapiazza RF; Cowan CE; Horne MC
    J Biol Chem; 2012 Jun; 287(27):22838-53. PubMed ID: 22589537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation-induced radioresistance in muscle cells.
    Latella L; Lukas J; Simone C; Puri PL; Bartek J
    Mol Cell Biol; 2004 Jul; 24(14):6350-61. PubMed ID: 15226436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of ataxia telangiectasia-mutated DNA damage checkpoint signal transduction elicited by herpes simplex virus infection.
    Shirata N; Kudoh A; Daikoku T; Tatsumi Y; Fujita M; Kiyono T; Sugaya Y; Isomura H; Ishizaki K; Tsurumi T
    J Biol Chem; 2005 Aug; 280(34):30336-41. PubMed ID: 15964848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. hMOB2 deficiency impairs homologous recombination-mediated DNA repair and sensitises cancer cells to PARP inhibitors.
    Gundogdu R; Erdogan MK; Ditsiou A; Spanswick V; Garcia-Gomez JJ; Hartley JA; Esashi F; Hergovich A; Gomez V
    Cell Signal; 2021 Nov; 87():110106. PubMed ID: 34363951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ataxia-telangiectasia-like disorder (ATLD)-its clinical presentation and molecular basis.
    Taylor AM; Groom A; Byrd PJ
    DNA Repair (Amst); 2004; 3(8-9):1219-25. PubMed ID: 15279810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDK4 inhibition restores G(1)-S arrest in MYCN-amplified neuroblastoma cells in the context of doxorubicin-induced DNA damage.
    Gogolin S; Ehemann V; Becker G; Brueckner LM; Dreidax D; Bannert S; Nolte I; Savelyeva L; Bell E; Westermann F
    Cell Cycle; 2013 Apr; 12(7):1091-104. PubMed ID: 23462184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
    Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
    Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chk1 and Wee1 control genotoxic-stress induced G2-M arrest in melanoma cells.
    Vera J; Raatz Y; Wolkenhauer O; Kottek T; Bhattacharya A; Simon JC; Kunz M
    Cell Signal; 2015 May; 27(5):951-60. PubMed ID: 25683911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct functions of Nijmegen breakage syndrome in ataxia telangiectasia mutated-dependent responses to DNA damage.
    Lee JH; Xu B; Lee CH; Ahn JY; Song MS; Lee H; Canman CE; Lee JS; Kastan MB; Lim DS
    Mol Cancer Res; 2003 Jul; 1(9):674-81. PubMed ID: 12861053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylated Hsp27 activates ATM-dependent p53 signaling and mediates the resistance of MCF-7 cells to doxorubicin-induced apoptosis.
    Xu Y; Diao Y; Qi S; Pan X; Wang Q; Xin Y; Cao X; Ruan J; Zhao Z; Luo L; Liu C; Yin Z
    Cell Signal; 2013 May; 25(5):1176-85. PubMed ID: 23357534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topoisomerase poisons differentially activate DNA damage checkpoints through ataxia-telangiectasia mutated-dependent and -independent mechanisms.
    Siu WY; Lau A; Arooz T; Chow JP; Ho HT; Poon RY
    Mol Cancer Ther; 2004 May; 3(5):621-32. PubMed ID: 15141020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression.
    Kang J; Ferguson D; Song H; Bassing C; Eckersdorff M; Alt FW; Xu Y
    Mol Cell Biol; 2005 Jan; 25(2):661-70. PubMed ID: 15632067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective Mre11-dependent activation of Chk2 by ataxia telangiectasia mutated in colorectal carcinoma cells in response to replication-dependent DNA double strand breaks.
    Takemura H; Rao VA; Sordet O; Furuta T; Miao ZH; Meng L; Zhang H; Pommier Y
    J Biol Chem; 2006 Oct; 281(41):30814-23. PubMed ID: 16905549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p53-p21WAF1 checkpoint pathway plays a protective role in preventing DNA rereplication induced by abrogation of FOXF1 function.
    Lo PK; Lee JS; Sukumar S
    Cell Signal; 2012 Jan; 24(1):316-24. PubMed ID: 21964066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sterigmatocystin-induced DNA damage triggers G2 arrest via an ATM/p53-related pathway in human gastric epithelium GES-1 cells in vitro.
    Zhang D; Cui Y; Shen H; Xing L; Cui J; Wang J; Zhang X
    PLoS One; 2013; 8(5):e65044. PubMed ID: 23705030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NBS1 is regulated by two kind of mechanisms: ATM-dependent complex formation with MRE11 and RAD50, and cell cycle-dependent degradation of protein.
    Zhou H; Kawamura K; Yanagihara H; Kobayashi J; Zhang-Akiyama QM
    J Radiat Res; 2017 Jul; 58(4):487-494. PubMed ID: 28369484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMC1-mediated intra-S-phase arrest facilitates bocavirus DNA replication.
    Luo Y; Deng X; Cheng F; Li Y; Qiu J
    J Virol; 2013 Apr; 87(7):4017-32. PubMed ID: 23365434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Widdrol activates DNA damage checkpoint through the signaling Chk2-p53-Cdc25A-p21-MCM4 pathway in HT29 cells.
    Yun HJ; Hyun SK; Park JH; Kim BW; Kwon HJ
    Mol Cell Biochem; 2012 Apr; 363(1-2):281-9. PubMed ID: 22160829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stalled replication induces p53 accumulation through distinct mechanisms from DNA damage checkpoint pathways.
    Ho CC; Siu WY; Lau A; Chan WM; Arooz T; Poon RY
    Cancer Res; 2006 Feb; 66(4):2233-41. PubMed ID: 16489026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.